Cigna worked with InformedDNA to come up with scenarios under which it would cover whole-exome sequencing, although it still considers whole-genome analysis investigational.
The evidence-based "Choosing Wisely" suggestions are meant to facilitate conversation between doctors and patients about unnecessary and wasteful interventions.
The organization argues that clinical utility should be defined by more than whether a test leads to an intervention that results in an improved outcome.
The workgroup has created standard categories for variant classification and has outlined a process for mitigating classification disagreements among labs.
JHU's Joshua Sharfstein and UNC's James Evans penned editorials for and against FDA's efforts to regulate lab tests ahead of a public meeting Jan. 8-9.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
